Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-29
DOI
10.3389/fimmu.2022.858399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity and association with virus neutralization test
- (2021) Antonin Bal et al. CLINICAL CHEMISTRY
- Prevalence and Predictors of SARS‐CoV‐2 Antibodies among Solid Organ Transplant Recipients with Confirmed Infection
- (2021) Daniel Burack et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies
- (2021) Fabrizio Bonelli et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
- (2021) Jan Van Elslande et al. JOURNAL OF CLINICAL VIROLOGY
- Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
- (2021) Ayelet Grupper et al. Clinical Journal of the American Society of Nephrology
- Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays among infected, recovered, and vaccinated groups
- (2021) Madhusudhanan Narasimhan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls
- (2021) Benedikt Simon et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
- (2021) Catherine J. Reynolds et al. SCIENCE
- Correlation of Vaccine Responses
- (2021) Petra Zimmermann et al. Frontiers in Immunology
- Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
- (2021) Syed Ali Husain et al. Kidney International Reports
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
- (2021) Bezawit A Woldemeskel et al. CLINICAL INFECTIOUS DISEASES
- The who international standard for covid-19 serological tests: towards harmonization of anti-spike assays
- (2021) Maria Infantino et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
- (2021) David Hagin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
- (2021) Ottavia M. Delmonte et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
- (2021) Jan Havlin et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
- (2021) Didier Ducloux et al. KIDNEY INTERNATIONAL
- Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
- (2021) Michela Antonelli et al. LANCET INFECTIOUS DISEASES
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
- (2021) Sokratis A. Apostolidis et al. NATURE MEDICINE
- Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
- (2021) Daniel Grupel et al. VACCINE
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
- (2021) Monika Strengert et al. EBioMedicine
- Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
- (2021) Maria Pia Sormani et al. EBioMedicine
- Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
- (2021) Soumya Jaganathan et al. Infectious Diseases and Therapy
- Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
- (2021) Natacha Madelon et al. CLINICAL INFECTIOUS DISEASES
- Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV
- (2021) Jessica J. Tuan et al. HIV MEDICINE
- Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects
- (2021) Michele N. Pham et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
- (2021) Anat Achiron et al. JOURNAL OF NEUROIMMUNOLOGY
- Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study
- (2021) Jens Van Praet et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
- (2021) Kristin Schmiedeberg et al. Lancet Rheumatology
- Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers
- (2021) Mónica Martínez-Gallo et al. MEDICINA CLINICA
- Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis
- (2020) Ya Gao et al. JOURNAL OF INFECTION
- COVID-19 in Immunocompromised Hosts: What We Know So Far
- (2020) Monica Fung et al. CLINICAL INFECTIOUS DISEASES
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- T cell immunity to SARS-CoV-2 following natural infection and vaccination
- (2020) Anthony T. DiPiazza et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started